编号：2022-003 投资者关 特定对象调研 分析师会议 系活动类 □媒体采访 □业绩说明会 别 □新闻发布会 □路演活动 现场参观 其他 电话会议 【兴业证券】：赵树理、侯宜芳；【万家基金】：王晨曦；【南银理财】： 参与单位 钱晟；【财通基金】：金梓才、夏钦、沈犁、张胤、贾雅楠；【平安养 名称及人 老】：徐唯俊；【太平基金】：徐琳；【银河基金】：金寿鹏；【华泰 员姓名 保兴】：石正杰、黄佳丽。 证券代码：301108 证券简称：洁雅股份 铜陵洁雅生物科技股份有限公司 投资者关系活动记录表 | --- | --- | |-------------------|---------------------------------------------------------------------------------------------| | | | | 时间 | 2022 年 1 月 17 日 至 2022 年 1 月 18 日 | | 地点 | 铜陵市狮子山经济开发区地质大道 528 号 铜陵洁雅生物科技股份有限公司会议室 | | 上市公司 接待人员 | 副总经理、董事会秘书：胡能华 证券事务代表 ...

证券代码：301108 证券简称：洁雅股份 铜陵洁雅生物科技股份有限公司 投资者关系活动记录表 编号：2022-001 | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | |-------------------------|------------------------|--------------------------------|------------------------------------------------------|-------|-------|-------|-------|-------|-------| | | | | | | | | | | | | 投资者关系活动 | 特定对象调研 | | 分析师会议 | | | | | | | | 类别 | | □新闻发布会 □路演活动 | □媒体采访 □业绩说明会 | | | | | | | | | □现场参观 | | 其他 | | | | | | | | | | | | | | | | | | | 参与单位名称及 人员姓名 | 信达证券 汲肖飞 | | | ...

证券代码：301108 证券简称：洁雅股份 铜陵洁雅生物科技股份有限公司 投资者关系活动记录表 编号：2022-002 | --- | --- | --- | --- | |-------------------------|------------------------------|---------------------------------------------------------------------------------------------------------------|-------| | | | | | | | 特定对象调研 | 分析师会议 | | | 投资者关系活动 | | □媒体采访 □业绩说明会 | | | 类别 | | □新闻发布会 □路演活动 | | | | □现场参观 | 其他 电话会议 | | | | | 【信达证券】：汲肖飞；【丰岭资本】：李浩田；【信诚基 | | | | | 金】：邹伟；【建投资管】：易杰锋；【信达澳银】：马绮 | | | | | 雯；【华富基金】：聂嘉雯；【兴业全球基金】：余喜洋； 【富国基金】：林浩祥；【长城基金】：刘疆；【睿亿投资 ...

编号：2022-007 证券代码：301108 证券简称：洁雅股份 铜陵洁雅生物科技股份有限公司 投资者关系活动记录表 | --- | --- | --- | |--------------------------|-----------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | | 特定对象调研 | 分析师会议 | | 投资者关 | | □媒体采访 □业绩说 ...

编号：2022-009 证券代码：301108 证券简称：洁雅股份 铜陵洁雅生物科技股份有限公司 投资者关系活动记录表 | --- | --- | --- | |---------------------------|------------------------------------|-------------------------------------------------------------------------------------------------------| | | 特定对象调研 | 分析师会议 | | | □媒体采访 | 业绩说明会 | | 投资者关系活 | □新闻发布会 □路演活动 | | | 动类别 | 现场参观 | 其他 2022 年安徽辖区上市公司投资者 | | | 网上集体接待日活动） | | | 参与单位名称 | 线上参与 2022 | 年安徽辖区上市公司投资者网上集体接待日活动的中 | | 及人员姓名 | 小投资者及机构投资者 | | | 时间 | 2022 年 9 月 7 日 | 16:00-17:30 | | 地点 | "全景路演"（ | http:/ ...

[Major Financial Data](index=2&type=section&id=Item%20I.%20Major%20Financial%20Data) The company reported significant year-on-year declines in revenue and net profit for Q3 and YTD, driven by reduced disinfectant wipe sales, while strong operating cash flow and strategic investments in wealth management products impacted financial metrics [Overview of Core Financial Indicators](index=2&type=section&id=Item%20%28I%29.%20Major%20Accounting%20Data%20and%20Financial%20Indicators) The company experienced significant year-on-year declines in Q3 and YTD operating revenue and net profit, while YTD net cash flow from operating activities increased by 34.63% Key Financial Indicators for Q3 2022 and Year-to-Date | Indicator | Current Period (Q3 2022) | YoY Change (Current Period) | Year-to-Date (YTD) | YoY Change (YTD) | | :--- | :--- | :--- | :--- | :--- | | Operating Revenue (Yuan) | 166,100,000 | -11.62% | 525,640,000 | -35.46% | | Net Profit Attributable to Shareholders of Listed Company (Yuan) | 39,780,000 | -17.10% | 128,930,000 | -30.37% | | Net Cash Flow from Operating Activities (Yuan) | -- | -- | 251,100,000 | 34.63% | | Basic Earnings Per Share (Yuan/share) | 0.49 | -37.97% | 1.59 | -47.70% | | Weighted Average Return on Net Assets (%) | 2.28% | -5.68% | 7.45% | -27.22% | | **Balance Sheet (Period End)** | **End of Current Period** | **End of Previous Year** | **Change** | | | Total Assets (Yuan) | 2,108,460,000 | 2,052,530,000 | 2.73% | | | Total Equity Attributable to Shareholders of Listed Company (Yuan) | 1,763,710,000 | 1,693,430,000 | 4.15% | | [Analysis of Non-Recurring Gains and Losses](index=2&type=section&id=Item%20%28II%29.%20Non-Recurring%20Gains%20and%20Losses%20Items%20and%20Amounts) Year-to-date, total non-recurring gains and losses were 3.35 million Yuan, primarily from government grants, offset by fair value changes and non-operating expenses Non-Recurring Gains and Losses Items Year-to-Date (Unit: Yuan) | Item | Amount Year-to-Date | Description | | :--- | :--- | :--- | | Government Grants Included in Current Profit/Loss | 8,590,000 | Major positive impact | | Gains/Losses from Changes in Fair Value of Financial Assets/Liabilities Held for Trading | -2,260,000 | Major negative impact | | Other Non-Operating Income and Expenses | -2,240,000 | Major negative impact | | **Total** | **3,350,000** | -- | [Analysis of Changes in Major Financial Indicators and Their Causes](index=3&type=section&id=Item%20%28III%29.%20Changes%20in%20Major%20Accounting%20Data%20and%20Financial%20Indicators%20and%20Their%20Causes) Several financial indicators changed significantly due to decreased disinfectant wipe sales, impacting revenue and costs, while increased investment in wealth management products boosted financial assets and investment income, and higher interest and exchange gains reduced financial expenses - Operating revenue decreased by **35.46%** year-on-year, primarily due to a significant reduction in sales of disinfectant wipes[10](index=10&type=chunk) - Financial expenses decreased significantly by **2489.31%** year-on-year, mainly due to increased interest income and exchange gains[10](index=10&type=chunk) - Contract liabilities surged by **327.87%** year-on-year, primarily due to increased advance payments from customers[10](index=10&type=chunk) - The generation and significant increase in investment income and financial assets held for trading were primarily due to the company's use of idle raised funds to purchase wealth management products[10](index=10&type=chunk)[11](index=11&type=chunk) [Shareholder Information](index=4&type=section&id=Item%20II.%20Shareholder%20Information) The company's equity structure is highly concentrated, with the controlling shareholder and spouse holding over 55% of shares among 11,722 common shareholders [Common Shareholder Holdings](index=4&type=section&id=Item%20%28I%29.%20Total%20Number%20of%20Common%20Shareholders%2C%20Number%20of%20Preferred%20Shareholders%20with%20Restored%20Voting%20Rights%2C%20and%20Top%20Ten%20Shareholders%27%20Holdings%20Table) As of the reporting period, the company had 11,722 common shareholders, with a highly concentrated equity structure where the controlling shareholder and spouse hold over 55% - As of the end of the reporting period, the company had **11,722** common shareholders[13](index=13&type=chunk) Top Ten Shareholders' Holdings | Shareholder Name | Shareholder Type | Holding Percentage | Number of Shares Held | | :--- | :--- | :--- | :--- | | Cai Yingchuan | Domestic Natural Person | 52.88% | 42,946,052 | | Tongling Mingyuan Venture Capital Management Co., Ltd... | Other | 10.29% | 8,360,000 | | Feng Yan | Domestic Natural Person | 2.66% | 2,164,030 | | Cai Shuguang | Domestic Natural Person | 2.29% | 1,860,746 | | Suzhou Industrial Park Zhongyi Mingyuan Venture Capital... | Other | 1.48% | 1,204,926 | - Controlling shareholder Mr. Cai Yingchuan and his spouse Ms. Feng Yan are parties acting in concert, and Tongling Mingyuan and Suzhou Industrial Park Zhongyi Mingyuan are both ultimately controlled by Yang Xuming[14](index=14&type=chunk) [Other Significant Matters](index=5&type=section&id=Item%20III.%20Other%20Significant%20Matters) The company implemented a restricted stock incentive plan for core employees and established a wholly-owned subsidiary to enhance supply chain security and competitiveness [2022 Restricted Stock Incentive Plan](index=5&type=section&id=1.%202022%20Restricted%20Stock%20Incentive%20Plan) In August 2022, the company granted 1.684 million Class II restricted shares to 56 core employees to establish a long-term incentive mechanism - On August 1, 2022, the company initially granted **1.684 million** Class II restricted shares to **56** incentive recipients[15](index=15&type=chunk) [Establishment of Wholly-Owned Subsidiary](index=5&type=section&id=2.%20Establishment%20of%20Wholly-Owned%20Subsidiary) In September 2022, the company established "Jieya Investment (Tongling) Co., Ltd." with 10 million Yuan of its own funds to enhance supply chain security and competitiveness - The company established a wholly-owned subsidiary, "Jieya Investment (Tongling) Co., Ltd.," with an investment of **10 million Yuan** from its own funds[17](index=17&type=chunk) - The strategic purpose of establishing this subsidiary is to ensure supply chain security, integrate upstream and downstream resources, and enhance the company's overall competitive strength and profitability[17](index=17&type=chunk) [Quarterly Financial Statements](index=6&type=section&id=Item%20IV.%20Quarterly%20Financial%20Statements) The company's Q3 2022 financial statements show a slight increase in total assets driven by wealth management investments, significant year-on-year declines in revenue and net profit due to reduced product demand, and strong operating cash flow offset by substantial investment outflows [Consolidated Balance Sheet](index=6&type=section&id=1.%20Consolidated%20Balance%20Sheet) As of September 30, 2022, total assets increased slightly to 2.11 billion Yuan, driven by a significant rise in financial assets held for trading due to wealth management product purchases, while total liabilities decreased, maintaining a low asset-liability ratio Major Balance Sheet Item Changes (Unit: Yuan) | Item | September 30, 2022 | January 1, 2022 | Change | | :--- | :--- | :--- | :--- | | **Total Assets** | **2,108,460,000** | **2,052,530,000** | **+2.73%** | | Cash and Cash Equivalents | 1,212,710,000 | 1,415,560,000 | -14.33% | | Financial Assets Held for Trading | 350,160,000 | 0 | N/A | | Inventory | 90,500,000 | 142,630,000 | -36.55% | | **Total Liabilities** | **344,750,000** | **359,100,000** | **-3.99%** | | Contract Liabilities | 48,010,000 | 11,220,000 | +327.87% | | **Total Equity** | **1,763,710,000** | **1,693,430,000** | **+4.15%** | [Consolidated Income Statement (Year-to-Date)](index=8&type=section&id=2.%20Consolidated%20Income%20Statement%20Year-to-Date) In the first three quarters of 2022, operating revenue decreased by 35.46% and net profit by 30.37%, primarily due to reduced demand for disinfectant wipes, with increased administrative expenses and asset impairment losses contributing to the profit decline Major Income Statement Items (Year-to-Date, Unit: Yuan) | Item | Current Period Amount (2022 YTD) | Prior Period Amount (2021 YTD) | YoY Change | | :--- | :--- | :--- | :--- | | Operating Revenue | 525,640,000 | 814,500,000 | -35.46% | | Operating Cost | 351,030,000 | 547,300,000 | -35.86% | | Financial Expenses | -27,710,000 | 1,160,000 | -2489.31% | | Total Profit | 148,220,000 | 212,170,000 | -30.14% | | Net Profit | 128,930,000 | 185,160,000 | -30.37% | [Consolidated Cash Flow Statement (Year-to-Date)](index=10&type=section&id=3.%20Consolidated%20Cash%20Flow%20Statement%20Year-to-Date) In the first three quarters of 2022, net cash flow from operating activities increased by 34.63% to 251 million Yuan, while investing activities saw a net outflow of 372 million Yuan due to wealth management product purchases, and financing activities had a net outflow of 60.91 million Yuan for dividends, leading to an overall 173 million Yuan net decrease in cash and cash equivalents Major Cash Flow Statement Items (Year-to-Date, Unit: Yuan) | Item | Current Period Amount (2022 YTD) | Prior Period Amount (2021 YTD) | | :--- | :--- | :--- | | Net Cash Flow from Operating Activities | 251,100,000 | 186,510,000 | | Net Cash Flow from Investing Activities | -371,670,000 | -68,800,000 | | Net Cash Flow from Financing Activities | -60,910,000 | -45,260,000 | | Net Increase in Cash and Cash Equivalents | -173,280,000 | 70,830,000 | - Cash outflow from investing activities was primarily due to the payment of **450 million Yuan** for wealth management products[26](index=26&type=chunk) - Cash outflow from financing activities was mainly for the payment of **60.91 million Yuan** for dividend distribution, profit, or interest repayment[27](index=27&type=chunk)

证券代码：301108 证券简称：洁雅股份 公告编号：2022-064 铜陵洁雅生物科技股份有限公司 关于参加安徽辖区上市公司 2022 年投资者 网上集体接待日活动的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 为进一步加强与投资者的互动交流，铜陵洁雅生物科技股份有限公司（以下 简称"公司"）将参加由安徽证监局指导、安徽上市公司协会与深圳市全景网络 有限公司联合举办的"2022 年安徽辖区上市公司投资者集体接待日活动"，现 将相关事项公告如下： 本次活动将采用网络远程的方式举行，投资者可登录"全景路演"网站 （http://rs.p5w.net），或关注微信公众号：全景财经，或下载全景路演 APP,参与 本次互动交流，活动时间为 2022 年 9 月 7 日（周三）16:00-17:30。届时公司高 管将在线就公司 2022 年半年度报告中的公司业绩、公司治理、发展战略、经营 状况、融资计划、股权激励和可持续发展等投资者关心的问题，与投资者进行沟 通与交流，欢迎广大投资者踊跃参与！ 特此公告。 铜陵洁雅生物科技股份有限公司董事会 2022 年 9 月 ...

Financial Performance - The company's operating revenue for the first half of 2022 was approximately ¥359.55 million, a decrease of 42.62% compared to ¥626.57 million in the same period last year[22]. - The net profit attributable to shareholders of the listed company was approximately ¥89.16 million, down 35.01% from ¥137.18 million in the previous year[22]. - Basic earnings per share decreased by 51.11% to ¥1.10, down from ¥2.25 in the previous year[22]. - The weighted average return on net assets was 5.16%, a decline of 21.73% from 26.89% in the previous year[22]. - The gross margin for wet wipes was 28.90%, down 1.88% from the previous year, while the gross margin for facial masks was 52.07%, a decrease of 4.47%[53]. - The company's revenue for the first half of 2022 was CNY 359.55 million, a decrease of 42.62% compared to CNY 626.57 million in the same period last year, primarily due to a significant drop in sales of disinfectant wet wipes[51]. - The cost of sales also decreased by 42.67% to CNY 242.66 million from CNY 423.29 million, reflecting the same decline in product sales[51]. - Research and development expenses were reduced by 43.43% to CNY 13.39 million from CNY 23.66 million, indicating a decrease in investment in new product development[51]. - The company reported a comprehensive income total of CNY 89,155,653.9 for the period, reflecting the overall financial performance despite cash flow challenges[169]. Cash Flow and Assets - The net cash flow from operating activities increased by 36.97% to approximately ¥139.35 million, compared to ¥101.73 million in the same period last year[22]. - Cash and cash equivalents at the end of the reporting period amounted to ¥1,187,452,933.09, representing 57.35% of total assets, a decrease of 11.62% compared to the previous year[57]. - Accounts receivable increased to ¥177,424,329.08, accounting for 8.57% of total assets, up by 0.68% year-on-year[57]. - Inventory decreased to ¥100,747,364.77, making up 4.87% of total assets, down by 2.08% due to a reduction in stock[57]. - Total assets at the end of the reporting period were approximately ¥2.07 billion, an increase of 0.88% from ¥2.05 billion at the end of the previous year[22]. - The total cash inflow from investment activities was CNY 50,685,000.00, compared to CNY 25,612.20 in the previous year, indicating a significant increase in investment returns[167]. - The total cash and cash equivalents at the end of the period were CNY 1,104,537,565.32, down from CNY 1,337,945,001.60 at the beginning of the period, a decrease of approximately 17.5%[168]. Investment and Fundraising - The company reported a net fundraising amount of ¥1,031,831,424.91 after deducting issuance costs from the total fundraising of ¥1,162,721,769.66[66]. - The total amount raised from the initial public offering was approximately RMB 1.16 billion, with a net amount of RMB 1.03 billion after deducting issuance costs[69]. - The company plans to use RMB 1.9 billion of the raised funds to permanently supplement working capital, ensuring the funding needs for investment projects are met[70]. - The company has committed to several investment projects, including a multifunctional wet wipes expansion project with an investment of RMB 26.09 million, which is currently under construction[69]. - The total amount of over-raised funds is RMB 656.08 million, which is being allocated for various projects and working capital[70]. Risks and Challenges - The company faces risks related to technology research and development, particularly in the wet wipes industry, which requires expertise across multiple disciplines[78]. - The company is exposed to raw material price fluctuation risks, as direct materials constitute a significant portion of the main business costs[79]. - The company has a high customer concentration risk, relying heavily on major clients such as Reckitt Group and Procter & Gamble for revenue[80]. - The company is adopting an ODM/OEM model, which poses risks related to brand recognition and market expansion for its own products[82]. - The company is vigilant about changes in import policies of export countries, which could affect its revenue and profit margins[87]. Corporate Governance and Management - The company appointed a new CFO, Yang Fanlong, on April 26, 2022, after the previous CFO, Wang Cuixia, resigned for personal reasons[98]. - The board of directors underwent a significant reshuffle on June 27, 2022, with multiple new appointments including the chairman, Cai Yingchuan, and several independent directors[99]. - The company has a stable management team with over ten years of service, contributing to improved operational efficiency and profitability[48]. - The company has not faced any administrative penalties related to environmental issues during the reporting period[104]. - The company has maintained good integrity status without any overdue debts or unfulfilled commitments[120]. Research and Development - The company focuses on independent research and development, ensuring compliance with legal standards and product performance metrics[40]. - The company has established a comprehensive quality management system based on international standards, which has facilitated partnerships with major global retail brands[44]. - The company has achieved dual certification for its environmental management (ISO 14001:2015) and occupational health and safety management (ISO 45001:2018) systems[106]. - The company aims to enhance its research and development efforts to drive future growth and innovation[172]. Shareholder Information - The company had a total of 81,209,818 shares outstanding, with 100% of shares accounted for[141]. - The largest shareholder, 蔡英传, holds 42,946,052 shares, representing a significant portion of the total shares[143]. - The company plans to maintain its current shareholder structure with no immediate changes anticipated[145]. - The next scheduled release of limited sale shares is set for December 3, 2022, for several shareholders[143].